MEDICAL MARIJUANA, INC.: CEO Chosen to Present Oral Comments at FDA's Public Hearing on Products Containing Cannabis and Cannabis-Derived Compounds


Medical Marijuana, Inc. issued the following announcement on May 21.

Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, announced today that the Company's CEO, Dr. Stuart Titus, has been chosen as one of 65 speakers to present oral comments at the U.S. Food & Drug Administration (FDA)'s upcoming public hearing discussing scientific data and information about products containing cannabis-derived compounds. Titus was chosen from nearly 400 applicants and will give his oral comments between 8:00 a.m. and 10:30 a.m. on Friday, May 31, 2019.

"I'm honored to be given this opportunity to speak on a national stage about why cannabidiol (CBD) as derived from industrial hemp and in its botanical form, should be allowed as a dietary supplement and food ingredient. We believe that hemp-derived CBD represents the quintessential dietary supplement and I am thrilled to speak to this before our US FDA," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.

According to the FDA, the goal of the hearing is to obtain additional scientific data and other information related to cannabis and cannabis-derived compounds, both from botanical and synthetic sources, to inform our regulatory oversight of these products. Speakers at the FDA meeting will include cannabis industry pioneers, political leaders, scientists, and medical doctors who have been influential in the legalization of the industrial hemp and its derivatives.

Dr. Titus is a 10-year pioneer of the cannabis industry and has been involved in all aspects of the medical marijuana and industrial hemp industries. Through his leadership, Medical Marijuana, Inc. became the first company to deliver cannabis brands across U.S. state lines and international borders, making hemp-derived CBD available across the United States and in dozens of countries such as Mexico, Brazil, Paraguay, Argentina and many European nations.

To watch his oral comments live, please visit: https://collaboration.fda.gov/cannabispart15.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.

Original source can be found here.

More News

FDA Reporter